The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...

Looking for help with today's New York Times Pips? We'll walk you through today's puzzle and help you match dominoes to tiles ...

In The Lancet in 1971, Julian Tudor Hart gave medicine one of its most important insights: the availability of medical care ...

This is the desktop equivalent of getting glasses and realizing you've been squinting for years.

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Original image has been ...

How good is your company at problem solving? Probably quite good, if your managers are like those at the companies I’ve studied. What they struggle with, it turns out, is not solving problems but ...

Five steps to ensure that you don’t jump to solutions by Julia Binder and Michael D. Watkins When business leaders confront complex problems, there’s a powerful impulse to dive right into “solving” ...

Business Insider's annual Seed 100 list recognizes the early-stage investors who provide crucial support to budding startups.

Susan Bard, MD, is a board-certified general and procedural dermatologist with the American Board of Dermatology and a Fellow of the American College of Mohs Surgery. Some of the most common skin ...